These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9139011)

  • 1. [Comparison of ultrasonographic results of the breast with progesterone levels in women with fibrocystic mastopathy].
    Urbanowicz Z; Buchacz P; Poreba R; Noras K
    Ginekol Pol; 1996 Aug; 67(8):411-3. PubMed ID: 9139011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The steroid and peptide hormone content of the blood in women with different forms of fibrocystic mastopathy].
    Serov VN; Tumilovich LG; Rozhkova NI; Samoĭlova TE
    Akush Ginekol (Mosk); 1988 Mar; (3):54-6. PubMed ID: 3400830
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ultrasonography in the diagnosis of diffuse fibrocystic mastopathy].
    Trofimova TN; Solntseva IA
    Vestn Rentgenol Radiol; 1999; (4):17-20. PubMed ID: 11082686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal correlations in uterine myoma, internal endometriosis and diffuse mastopathy in patients with a retained biphasic menstrual cycle].
    Sokolova ZP
    Akush Ginekol (Mosk); 1982 Jun; (6):15-9. PubMed ID: 6812446
    [No Abstract]   [Full Text] [Related]  

  • 6. Endocrinology of benign breast disease in relation to the severity of radiological dysplasia.
    Junkermann H; Klinga K; Weber E; von Fournier D
    Horm Res; 1989; 32 Suppl 1():10-4. PubMed ID: 2613196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonal contraception and benign breast disease. Evaluation of a treatment protocol for chronic mastopathy with mastalgia].
    Leonardi M
    Minerva Ginecol; 1997 Jun; 49(6):271-6. PubMed ID: 9289667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Depo-Provera treatment of mastopathy patients].
    Khomasuridze AG; Manusharova RA
    Lik Sprava; 1993; (10-12):104-6. PubMed ID: 8030291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen in the serum of women with benign breast disease.
    Radowicki S; Kunicki M; Bandurska-Stankiewicz E
    Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):212-6. PubMed ID: 17850950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
    Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
    Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of fibrocystic breast disease with lisuride].
    López Rosales C; Romero Espinosa RE; Juárez Vazquez J
    Ginecol Obstet Mex; 1991 Dec; 59():358-61. PubMed ID: 1819543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endocrinology of mastopathy and small breast cancer].
    Huber J; Vytiska E
    Wien Med Wochenschr; 1987 Mar; 137(5-6):116-9. PubMed ID: 3037805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic progestin therapy for the management of mastopathy and mastodynia.
    Winkler UH; Schindler AE; Brinkmann US; Ebert C; Oberhoff C
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():37-43. PubMed ID: 12227885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The concentrations of prolactin and estrogens in women with fibrocystic changes in the breast].
    Sieja K; Stanosz S
    Ginekol Pol; 2002 Jul; 73(7):594-9. PubMed ID: 12375569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of estradiol and progesterone receptors in the selection of endocrine therapy fo patients with fibrocystic mastopathy].
    Lucía Salazar E; Calzada L
    Ginecol Obstet Mex; 1993 May; 61():132-5. PubMed ID: 8486312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ultrasonographic images of fibrocystic mastopathy treated with bromocriptine].
    Garcí Roig F; Peña Cortés TH
    Ginecol Obstet Mex; 1986 Oct; 54():274-7. PubMed ID: 3539704
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of danazol treatment of women with fibrocystic disease of breast].
    Baranowska B; Stopińska-Głuszak U
    Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):771-3. PubMed ID: 2701752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of a correlation between CA15.3 and estradiol serum levels in women with fibrocystic (non macrocystic) mastopathy.
    Vizoso F; Allende MT; Diez MC; Ruibal A
    Int J Biol Markers; 1991; 6(1):33-4. PubMed ID: 1856515
    [No Abstract]   [Full Text] [Related]  

  • 20. [Levels of estrogen, progesterone, prolactin and sex hormone-binding globulin in the blood and breast cysts].
    Vlaisavljević V; Adamcic M
    Jugosl Ginekol Perinatol; 1986; 26(5-6):97-9. PubMed ID: 3657280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.